Quantifying the material and structural determinants of bone strength

More documents

Recommendations

Info

750 M.L. Bouxsein, E. Seeman / Best Practice & Research Clinical Rheumatology 23 (2009) 741–753 [20] Beck T. Measuring the structural strength of bones with dual-energy X-ray absorptiometry: principles, technical limitations, and future possibilities. Osteoporos Int 2003;14(Suppl. 5):81–8. [21] Uusi-Rasi K, Beck TJ, Semanick LM, et al. Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial. Osteoporos Int 2006;17(4):575–86. [22] Greenspan SL, Beck TJ, Resnick NM, et al. Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial. J Bone Miner Res 2005;20(9): 1525–32. [23] Uusi-Rasi K, Semanick LM, Zanchetta JR, et al. Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 2005;36(6):948–58. [24] Bonnick SL, Beck TJ, Cosman F, et al. DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass. Osteoporos Int 2009;20(6):911–21. [25] Chen Z, Beck TJ, Cauley JA, et al. Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women’s Health Initiative hormone intervention trials. J Bone Miner Res 2008;23(12): 1935–45. [26] Boivin GY, Chavassieux PM, Santora AC, et al. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 2000;27(5):687–94. [27] Roschger P, Rinnerthaler S, Yates J, et al. Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 2001;29(2):185–91. [28] Boivin G, Lips P, Ott SM, et al. Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women. J Clin Endocrinol Metab 2003;88(9):4199–205. [29] Borah B, Ritman EL, Dufresne TE, et al. The effect of risedronate on bone mineralization as measured by microcomputed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover. Bone 2005; 37(1):1–9. [30] Misof BM, Roschger P, Cosman F, et al. Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 2003;88(3):1150–6. [31] Beck TJ, Oreskovic TL, Stone KL, et al. Structural adaptation to changing skeletal load in the progression toward hip fragility: the study of osteoporotic fractures. J Bone Miner Res 2001;16(6):1108–19. [32] Beck TJ, Stone KL, Oreskovic TL, et al. Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures. J Bone Miner Res 2001;16(11):2103–10. [33] Crabtree N, Lunt M, Holt G, et al. Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study. Bone 2000;27(1):151–9. [34] Nelson DA, Barondess DA, Hendrix SL, Beck TJ. Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women. J Bone Miner Res 2000;15(10):1992–7. [35] Looker AC, Beck TJ, Orwoll ES. Does body size account for gender differences in femur bone density and geometry? J Bone Miner Res 2001;16(7):1291–9. [36] Crabtree NJ, Kroger H, Martin A, et al. Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporos Int 2002;13(1):48–54. [37] Cauley JA, Lui LY, Stone KL, et al. Longitudinal study of changes in hip bone mineral density in Caucasian and African- American women. J Am Geriatr Soc 2005;53(2):183–9. [38] Kaptoge S, Dalzell N, Loveridge N, et al. Effects of gender, anthropometric variables, and aging on the evolution of hip strength in men and women aged over 65. Bone 2003;32(5):561–70. [39] Takada J, Beck TJ, Iba K, Yamashita T. Structural trends in the aging proximal femur in Japanese postmenopausal women. Bone 2007;41(1):97–102. [40] Kaptoge S, Jakes RW, Dalzell N, et al. Effects of physical activity on evolution of proximal femur structure in a younger elderly population. Bone 2007;40(2):506–15. [41] Kaptoge S, Dalzell N, Folkerd E, et al. Sex hormone status may modulate rate of expansion of proximal femur diameter in older women alongside other skeletal regulators. J Clin Endocrinol Metab 2007;92(1):304–13. [42] Demissie S, Dupuis J, Cupples LA, et al. Proximal hip geometry is linked to several chromosomal regions: genomewide linkage results from the Framingham Osteoporosis Study. Bone 2007;40(3):743–50. [43] Karasik D, Dupuis J, Cupples LA, et al. Bivariate linkage study of proximal hip geometry and body size indices: the Framingham study. Calcif Tissue Int 2007;81(3):162–73. [44] Streeten EA, Beck TJ, O’Connell JR, et al. Autosome-wide linkage analysis of hip structural phenotypes in the Old Order Amish. Bone 2008;43(3):607–12. [45] Szulc P, Duboeuf F, Schott AM, et al. Structural determinants of hip fracture in elderly women: re-analysis of the data from the EPIDOS study. Osteoporos Int 2006;17(2):231–6. [46] Ahlborg HG, Nguyen ND, Nguyen TV, et al. Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Miner Res 2005;20(10):1820–7. [47] Rivadeneira F, Zillikens MC, De Laet CE, et al. Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam Study. J Bone Miner Res 2007;22(11): 1781–90. [48] Kaptoge S, Beck TJ, Reeve J, et al. Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res 2008;23(12):1892–904. *[49] Riggs BL, Melton Iii 3rd LJ, Robb RA, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 2004;19(12):1945–54. [50] Marshall LM, Lang TF, Lambert LC, et al. Dimensions and volumetric BMD of the proximal femur and their relation to age among older U.S. men. J Bone Miner Res 2006;21(8):1197–206. [51] Sigurdsson G, Aspelund T, Chang M, et al. Increasing sex difference in bone strength in old age: the Age, Gene/ Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK). Bone 2006;39(3):644–51.
M.L. Bouxsein, E. Seeman / Best Practice & Research Clinical Rheumatology 23 (2009) 741–753 751 [52] Marshall LM, Zmuda JM, Chan BK, et al. Race and ethnic variation in proximal femur structure and BMD among older men. J Bone Miner Res 2008;23(1):121–30. [53] Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003;349(13):1207–15. [54] Finkelstein JS, Hayes A, Hunzelman JL, et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003;349(13):1216–26. [55] McClung MR, San Martin J, Miller PD, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 2005;165(15):1762–8. [56] Sellmeyer DE, Black DM, Palermo L, et al. Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis. Osteoporos Int 2007;18(7):973–9. [57] Lewiecki EM, Keaveny TM, Kopperdahl DL, et al. Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 2009;94(1): 171–80. [58] Miller PD, Delmas PD, Lindsay R, et al. Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J Clin Endocrinol Metab 2008;93(10):3785–93. [59] Duboeuf F, Jergas M, Schott AM, et al. A comparison of bone densitometry measurements of the central skeleton in post-menopausal women with and without vertebral fracture. Br J Radiol 1995;68(811):747–53. [60] Ito M, Ohki M, Hayashi K, et al. Trabecular texture analysis of CT images in the relationship with spinal fractures. Radiology 1995;194:55–9. [61] Grampp S, Genant H, Mathur A, et al. Comparisons of noninvasive bone mineral measurements in assessing agerelated loss, fracture discrimination, and diagnostic classification. J Bone Miner Res 1997;12:697–711. [62] Lang TF, Li J, Harris ST, Genant HK. Assessment of vertebral bone mineral density using volumetric quantitative CT. J Comput Assist Tomogr 1999;23(1):130–7. [63] Bergot C, Laval-Jeantet AM, Hutchinson K, et al. A comparison of spinal quantitative computed tomography with dual energy X-ray absorptiometry in European women with vertebral and nonvertebral fractures. Calcif Tissue Int 2001; 68(2):74–82. [64] Kroger H, Lunt M, Reeve J, et al. Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European quantitation of osteoporosis study. Calcif Tissue Int 1999;64(3): 191–9. [65] Lang TF, Guglielmi G, van Kuijk C, et al. Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone 2002;30(1):247–50. [66] Rehman Q, Lang T, Modin G, Lane NE. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy. Arthritis Rheum 2002;46(5): 1292–7. [67] Clowes JA, Eastell R, Peel NF. The discriminative ability of peripheral and axial bone measurements to identify proximal femoral, vertebral, distal forearm and proximal humeral fractures: a case control study. Osteoporos Int 2005; 16(12):1794–802. [68] Mackey DC, Eby JG, Harris F, et al. Prediction of clinical non-spine fractures in older black and white men and women with volumetric BMD of the spine and areal BMD of the hip: the Health, Aging, and Body Composition Study*. J Bone Miner Res 2007;22(12):1862–8. *[69] Black DM, Bouxsein ML, Marshall LM, et al. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. J Bone Miner Res 2008;23(8):1326–33. *[70] Ito M, Ikeda K, Nishiguchi M, et al. Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk. J Bone Miner Res 2005;20(10):1828–36. [71] Graeff C, Timm W, Nickelsen TN, et al. Monitoring teriparatide-associated changes in vertebral microstructure by highresolution CT in vivo: results from the EUROFORS study. J Bone Miner Res 2007;22(9):1426–33. *[72] Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular bone microarchitecture by highresolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 2005;90(12):6508–15. [73] Khosla S, Riggs BL, Atkinson EJ, et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res 2006;21(1):124–31. [74] Khosla S, Melton 3rd LJ, Achenbach SJ, et al. Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men. J Clin Endocrinol Metab 2005;91(3):885–91. [75] Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res 2007;22(3):425–33. [76] Melton 3rd LJ, Riggs BL, van Lenthe GH, et al. Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Miner Res 2007;22(9):1442–8. [77] Vico L, Zouch M, Amirouche A, et al. High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res 2008;23(11):1741–50. *[78] Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 2008;23(2):205–14. *[79] Kazakia GJ, Hyun B, Burghardt AJ, et al. In vivo determination of bone structure in postmenopausal women: a comparison of HR-pQCT and high-field MR imaging. J Bone Miner Res 2008;23(4):463–74. [80] Dalzell N, Kaptoge S, Morris N, et al. Bone micro-architecture and determinants of strength in the radius and tibia: age-related changes in a population-based study of normal adults measured with high-resolution pQCT. Osteoporos Int 2009;20(10):1683–94. [81] MacNeil JA, Boyd SK. Accuracy of high-resolution peripheral quantitative computed tomography for measurement of bone quality. Med Eng Phys 2007;29(10):1096–105.
Page 1 and 2: 3 Quantifying the material and stru
Page 3 and 4: M.L. Bouxsein, E. Seeman / Best Pra
Page 9: Conclusions Novel non-invasive tech
Page 13: M.L. Bouxsein, E. Seeman / Best Pra

Quantifying the material and structural determinants of bone strength

Create successful ePaper yourself

Delete template?

Save as template?